Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Silver

Showing results (101-110 of 232) with videos related to

Pageof 24
Sort By:
The Journal of Molecular Diagnostics : JMD|March 27, 2007
Amplification refractory mutation system, a highly sensitive and simple polymerase chain reaction assay, for the detection of JAK2 V617F mutation in chronic myeloproliferative disordersQiaofang Chen, Pin Lu, Amy V Jones, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 19, 2013
Ruxolitinib for myelofibrosis--an update of its clinical effectsHagop M Kantarjian, Richard T Silver, Rami S Komrokji, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 1999
Ly-49CB6 NK inhibitory receptor recognizes peptide-receptive H-2KbR C Su, S K Kung, E T Silver, et al.
The American Journal of Gastroenterology|April 1, 1993
Ranitidine is effective therapy for erosive esophagitisA R Euler, R H Murdock, T H Wilson, et al.
Leukemia & Lymphoma|May 1, 1992
Attempted prevention of blast crisis in chronic myeloid leukemia by the use of pulsed doses of cytarabine and lomustine. A Cancer and Leukemia Group B studyR T Silver, A Karanas, K B Dear, et al.
The American Journal of Medicine|March 1, 1978
Morbidity of staging laparotomy in Hodgkin's diseaseS Brogadir, M A Fialk, M Coleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of Cancer and Leukemia Group B 9013M L Hensley, B Peterson, R T Silver, et al.
Seminars in Hematology|April 1, 1987
Advances in chemotherapy for large cell lymphomaM Coleman, G Gerstein, A Topilow, et al.
Annals of Internal Medicine|November 15, 1994
A clinical rule to predict preserved left ventricular ejection fraction in patients after myocardial infarctionM T Silver, G A Rose, S D Paul, et al.
Environmental Health Perspectives|June 1, 1987
Immunological studies on mice exposed subacutely to methyl isocyanateA N Tucker, J R Bucher, D R Germolec, et al.
Pageof 24

Showing results (101-110 of 232) with videos related to

Sort By:
Pageof 24
The Journal of Molecular Diagnostics : JMD|March 27, 2007
Amplification refractory mutation system, a highly sensitive and simple polymerase chain reaction assay, for the detection of JAK2 V617F mutation in chronic myeloproliferative disordersQiaofang Chen, Pin Lu, Amy V Jones, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 19, 2013
Ruxolitinib for myelofibrosis--an update of its clinical effectsHagop M Kantarjian, Richard T Silver, Rami S Komrokji, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 1999
Ly-49CB6 NK inhibitory receptor recognizes peptide-receptive H-2KbR C Su, S K Kung, E T Silver, et al.
The American Journal of Gastroenterology|April 1, 1993
Ranitidine is effective therapy for erosive esophagitisA R Euler, R H Murdock, T H Wilson, et al.
Leukemia & Lymphoma|May 1, 1992
Attempted prevention of blast crisis in chronic myeloid leukemia by the use of pulsed doses of cytarabine and lomustine. A Cancer and Leukemia Group B studyR T Silver, A Karanas, K B Dear, et al.
The American Journal of Medicine|March 1, 1978
Morbidity of staging laparotomy in Hodgkin's diseaseS Brogadir, M A Fialk, M Coleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of Cancer and Leukemia Group B 9013M L Hensley, B Peterson, R T Silver, et al.
Seminars in Hematology|April 1, 1987
Advances in chemotherapy for large cell lymphomaM Coleman, G Gerstein, A Topilow, et al.
Annals of Internal Medicine|November 15, 1994
A clinical rule to predict preserved left ventricular ejection fraction in patients after myocardial infarctionM T Silver, G A Rose, S D Paul, et al.
Environmental Health Perspectives|June 1, 1987
Immunological studies on mice exposed subacutely to methyl isocyanateA N Tucker, J R Bucher, D R Germolec, et al.
Pageof 24